U.S. markets open in 7 hours 41 minutes
  • S&P Futures

    3,366.75
    +14.75 (+0.44%)
     
  • Dow Futures

    27,830.00
    +166.00 (+0.60%)
     
  • Nasdaq Futures

    11,453.25
    +46.00 (+0.40%)
     
  • Russell 2000 Futures

    1,512.30
    +7.90 (+0.53%)
     
  • Crude Oil

    40.21
    -0.01 (-0.02%)
     
  • Gold

    1,899.20
    +3.70 (+0.20%)
     
  • Silver

    23.79
    +0.30 (+1.26%)
     
  • EUR/USD

    1.1754
    +0.0028 (+0.24%)
     
  • 10-Yr Bond

    0.6770
    0.0000 (0.00%)
     
  • Vix

    26.37
    +0.10 (+0.38%)
     
  • GBP/USD

    1.2945
    +0.0024 (+0.19%)
     
  • USD/JPY

    105.5200
    +0.0900 (+0.09%)
     
  • BTC-USD

    10,830.22
    +34.18 (+0.32%)
     
  • CMC Crypto 200

    223.81
    +2.42 (+1.09%)
     
  • FTSE 100

    5,866.10
    -31.40 (-0.53%)
     
  • Nikkei 225

    23,184.93
    -0.19 (-0.00%)
     

NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Morgan Stanley Global Healthcare Conference.

Brad Gray, president and chief executive officer, is scheduled to present on Monday, September 14th, 2020 at 12:45 p.m. ET. Interested parties can access the live webcast with accompanying slides from the investor section of the company’s website at www.nanostring.com. The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.

About NanoString Technologies, Inc.

NanoString Technologies is a leading provider of life science tools for translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,500 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.

For more information, please visit www.nanostring.com.

NanoString, NanoString Technologies, the NanoString logo, nCounter and Prosigna are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200909006021/en/

Contacts

Doug Farrell
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768